Literature DB >> 10532604

Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.

A A Pineda1, E C Vamvakas, L D Gorden, J L Winters, S B Moore.   

Abstract

BACKGROUND: An increasing incidence of delayed hemolytic and delayed serologic transfusion reactions (DHTRs/DSTRs) has been seen at the Mayo Clinic since 1978. Recently, the average length of stay (LOS) for inpatients and the average number of red cell transfusions per inpatient (TPI) decreased, and the albumin and papain technique for RBC antibody detection was replaced by a polyethylene glycol technique. These changes may have affected the incidence of DHTRs/DSTRs. STUDY DESIGN AND METHODS: The diagnoses of DHTR and DSTR made at the Mayo Clinic from 1993 through 1998 were reviewed. These data were compared with previously published Mayo Clinic data from 1980 through 1992. The LOS for inpatients and the average TPI were also obtained from hospital data.
RESULTS: The incidence of DHTR/DSTR increased from 1 in 1899 in 1980 through 1992 to 1 in 1300 in the 1993 through 1998 period (p < 0.05). Similarly, DSTR increased from 1 in 2990 in 1980 through 1992 to 1 in 1612 in the 1993 through 1998 period (p < 0.05). The incidence of DHTR showed a trend toward decrease, from 1 in 5405 in 1980 through 1992 to 1 in 6715 in 1993 through 1998. No alloantibody specificities were statistically associated with DHTRs in 1993 through 1998, unlike in the 1980 through 1992 period. Moreover, the incidence of Jka antibodies increased in 1993 through 1998, while the incidence of other alloantibodies remained stable. Average LOS and TPI declined by 24.5 percent and 8.8 percent, respectively, between the two periods.
CONCLUSION: Recently, a trend toward a decrease in the incidence of DHTR and a significant increase in DSTRs has occurred at the Mayo Clinic. These changes are most likely due to a combination of factors, including a decrease in average LOS and the adoption of the polyethylene glycol antibody detection system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532604     DOI: 10.1046/j.1537-2995.1999.39101097.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  Twelve years of the Brazilian External Quality Assessment Program in Immunohematology: benefits of the program.

Authors:  Laércio Melo; Jordão Pellegrino; Celso Bianco; Lilian Castilho
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis.

Authors:  Eldad A Hod; Set A Sokol; James C Zimring; Steven L Spitalnik
Journal:  Int J Clin Exp Pathol       Date:  2008-05-30

Review 3.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

Review 4.  The hazards of blood transfusion in historical perspective.

Authors:  Harvey J Alter; Harvey G Klein
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

Review 5.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

6.  Kidd Blood Group Genotyping for Thalassemia Patient in Iran.

Authors:  Seyedeh Farzaneh Jalali; Arezoo Oodi; Azita Azarkeivan; Samira Gudarzi; Naser Amirizadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2020-04-29       Impact factor: 0.900

7.  Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study.

Authors:  Miho Okutsu; Hitoshi Ohto; Hiroyasu Yasuda; Kinuyo Kawabata; Satoshi Ono; Shunnichi Saito; Akiko Sugawara; Masami Kikuchi; Saori Miura; Youko Ishii; Kazuya Watanabe; Yuriko Tohyama; Kenneth E Nollet
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

8.  Blood-management programs: a clinical and administrative model with program implementation strategies.

Authors:  Christopher Tokin; Jose Almeda; Saurabh Jain; Jennifer Kim; Randy Henderson; Mitra Nadim; Linda Sher; Robert R Selby
Journal:  Perm J       Date:  2009

9.  Frequency of unexpected antibody and consideration during transfusion.

Authors:  Ki-Ho Ko; Byung-Hoon Yoo; Kye-Min Kim; Woo-Yong Lee; Jun-Heum Yon; Ki-Hyuk Hong; Tae-Hee Han
Journal:  Korean J Anesthesiol       Date:  2012-05-24

10.  Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd.

Authors:  M Vaziri; H JavadzadehShahshahani; M Moghaddam; N Taghvaee
Journal:  Iran J Ped Hematol Oncol       Date:  2015-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.